Lamisil and Fatigue - a phase IV clinical study of FDA data
Summary:
Fatigue is found among people who take Lamisil, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Lamisil and have Fatigue. It is created by eHealthMe based on reports of 13,046 people who have side effects when taking Lamisil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
13,046 people reported to have side effects when taking Lamisil.
Among them, 599 people (4.59%) have Fatigue.
What is Lamisil?
Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 13,653 Lamisil users for its effectiveness, alternative drugs and more.
What is Fatigue?
Fatigue (feeling of tiredness) is found to be associated with 5,393 drugs and 6,177 conditions by eHealthMe.
Number of Lamisil and Fatigue reports submitted per year:
Time on Lamisil when people have Fatigue *:
Gender of people who have Fatigue when taking Lamisil*:
Age of people who have Fatigue when taking Lamisil *:
Common drugs people take besides Lamisil *:
Common side effects people have besides Fatigue *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lamisil and have Fatigue?
Check whether Fatigue is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
Related studies
How severe was Fatigue and when was it recovered:
Expand to all the drugs that have ingredients of terbinafine hydrochloride:
Alternative drugs to, pros and cons of Lamisil:
- Lamisil (13,653 reports)
Common Lamisil side effects:
- Rashes (redness): 916 reports
- Itching: 743 reports
- Fever: 646 reports
- Fatigue (feeling of tiredness): 599 reports
- Weight decreased: 568 reports
Browse all side effects of Lamisil:
a b c d e f g h i j k l m n o p q r s t u v w x y zFatigue treatments and more:
- Fatigue (814,940 reports)
COVID vaccines that are related to Fatigue:
- Fatigue in Moderna COVID Vaccine
- Fatigue in Pfizer BioNTech Covid Vaccine
- Fatigue in Johnson and Johnson Covid Vaccine
Common drugs associated with Fatigue:
- Prednisone: 46,071 reports
- Humira: 38,407 reports
- Aspirin: 37,295 reports
- Methotrexate: 36,266 reports
- Enbrel: 32,387 reports
- Vitamin d: 23,634 reports
- Tysabri: 23,185 reports
- Omeprazole: 22,124 reports
- Metformin: 22,049 reports
- Gabapentin: 21,158 reports
All the drugs that are associated with Fatigue:
- Fatigue (5,393 drugs)
Common conditions associated with Fatigue:
- Multiple sclerosis: 66,133 reports
- Rheumatoid arthritis: 50,897 reports
- High blood pressure: 27,376 reports
- Multiple myeloma: 27,077 reports
- Pain: 21,635 reports
- Depression: 20,515 reports
- Hepatitis c: 19,082 reports
All the conditions that are associated with Fatigue:
- Fatigue (6,177 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on terbinafine hydrochloride (the active ingredients of Lamisil) and Lamisil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamin D and Retained Placenta Or Membranes - 5 seconds ago
- Bone Pain and drugs of ingredients of allopurinol - 5 seconds ago
- Tegsedi and Cellulitis Aggravated - 9 seconds ago
- Glivec and Vascular Stenosis - 11 seconds ago
- Moduretic 5-50 and Diverticulum - 22 seconds ago
- Mefenamic Acid and Ceclor drug interaction - 35 seconds ago
- Meloxicam and Acute Myeloid Leukaemia - 43 seconds ago
- Tylox vs. Exalgo - 45 seconds ago
- Hydrea and Tongue Disorder - 46 seconds ago
- Klonopin and Memory Loss - 49 seconds ago